Abstract
Inogatran, a novel direct low molecular weight thrombin inhibitor, given with, but not after, tissue-plasminogen activator, improves thrombolysis.
L Chen, W W Nichols, C Mattsson, A C Teger-Nilsson, T G Saldeen and J L Mehta
Journal of Pharmacology and Experimental Therapeutics June 1996, 277 (3) 1276-1283;